Grace Therapeutics's total assets for Q1 2025 were $69.72M, a decrease of -4.89% from the previous quarter. GRCE total liabilities were $10.35M for the fiscal quarter, a -10.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.